Recombinant outer membrane secretin PilQ 406-770 as a vaccine candidate for serogroup B Neisseria meningitidis

Vaccine

Volumn 30, Issue 9, 2012, Pages 1710-1714

  Haghi, Fakhri ^a   Peerayeh, Shahin Najar ^a   Siadat, Seyed Davar ^b   Zeighami, Habib ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Neisseria meningitidis; PilQ 406 770; Vaccine

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; IMMUNOGLOBULIN G; RECOMBINANT SECRETIN PIIQ; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NEISSERIA MENINGITIDIS; NEISSERIACEAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; VACCINATION; WHOLE CELL;

ANIMALS; ANTIBODIES, BACTERIAL; FEMALE; FIMBRIAE PROTEINS; FREUND'S ADJUVANT; IMMUNE SERA; IMMUNOGLOBULIN G; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS, SEROGROUP B; RECOMBINANT PROTEINS; SERUM BACTERICIDAL ANTIBODY ASSAY;

EID: 84856774999     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.076     Document Type: Article

References (29)

1. Vermont C.L., Dijken H.H., Kuipers A.J., van Limpt C.J.P., Keijzers W.C.M., van der Ende A., et al. Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine. Infect Immun 2003, 71:1650-1655.
2. Sun Y., Li Y., Exley R.M., Winterbotham M., Ison C., Smith H., et al. Identification of novel antigens that protect against systemic meningococcal infection. Vaccine 2005, 23:4136-4141.
3. Girard M.P., Preziosi M.P., Aguado M.T., Kieny M.P. A review of vaccine research and development: meningococcal disease. Vaccine 2006, 24:4692-4700.
4. Weynants V.E., Feron C.M., Goraj K.K., Bos M.P., Denoel P.A., Verlant V.G., et al. Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitides. Infect Immun 2007, 75:5434-5442.
5. Halperin S.A., Langley J.M., Smith B., Wunderli P., Kaufmanb L., Kimura A., et al. Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults. Vaccine 2007, 25:450-457.
6. Bambinia S., Muzzia A., Olcen P., Rappuolia R., Pizzaa M., Comanduccia M. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 2009, 27:2794-2803.
7. Collins R.F., Vidsen L., Derrick J.P., Ford R.C., Tonjum T. Analysis of the PilQ secretin from N. meningitidis by transmission electron microscopy reveals a dodecameric quaternary structure. J Bacteriol 2001, 183:3825-3832.
8. Harrison O.B., Robertson B.D., Faust S.N., Jepson M.A., Goldin R.D., Levin M., et al. Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili and PorA by N. meningitidis in vivo. Infect Immun 2002, 70:5193-5201.
9. Assalkhou R., Balasingham S., Collins R.F., Frye S.A., Davidsen T., Benam A.V., et al. The outer membrane secretin PilQ from N. meningitidis binds DNA. Microbiology 2007, 153:1593-1603.
10. Feavers I.M., Pizza M. Meningococcal protein antigens and vaccines. Vaccine 2009, 27:B42-B50.
11. Craig L., Volkmann N., Arvai A.S., Pique M.P., Yeager M., Egelman E.H., et al. Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol Cell 2006, 23:651-662.
12. Frye S.A., Assalkhou R., Collins R.F., Ford R.C., Peterson C., Derrick J.P., et al. Topology of the outer-membrane secretin PilQ from N. meningitidis. Microbiology 2006, 152:3751-3764.
13. Collins R.F., Frye S.A., Balasingham S., Ford R.C., Tønjum T., Derrick J.P. Interaction with type IV pili induces structural changes in the bacterial outer membrane secretin PilQ. J Biol Chem 2005, 280:18923-18930.
14. Poolman J.T., Denoel P., Feron C., Goraj K., Weynants V. Outer membrane vesicle based meningococcal vaccines. Handbook of meningococcal disease 2006, Wiley-VCH, Weinheim, p. 371-90.
15. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B., Harakeh H.S., Dykes J.K., et al. Standardization and a multilaboratory comparison of N meningitidis serogroup A and C serum bactericidal assays. Clin Diag Lab Immunol 1997, 4:156-167.
16. Wedege E., Caugant D.A., Froholm L.O., Zollinger W.D. Characterization of serogroup A and B strains of N. meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis. J Clin Microb 1991, 29:1486-1492.
17. Devoe I.W., Gilchrist J.E. Ultrastructure of pili and annular structures on the cell wall surface of N. meningitidis. Infect Immun 1974, 10:872-876.
18. Sambrook J., Russell D. Molecular cloning: a laboratory manual 2001, Cold Spring Harbor Laboratory Press, New York, p. 2344. 3rd ed.
19. Walker J.M. The protein protocols handbook 2002, Humana Press, Totowa, NJ, p. 15-20. 2nd ed.
20. Zhu D., Zhang Y., Barniak V., Bernfield L., Howell A., Zlotnick G. Evaluation of recombinant Lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model. Infect Immun 2005, 10:6838-6845.
21. Welsch J.A., Granoff D. Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal activity. Clin Vaccine Immunol 2007, 14:1596-1602.
22. Humphries H.E., Williams J.N., Blackstone R., Jolley K.A., Yuen H.M., Christodoulides M., et al. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis. Vaccine 2006, 24:36-44.
23. Ciabattini A., Giomarelli B., Parigi R., Chiavolini D., Pettini E., Arico B., et al. Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. Vaccine 2008, 26:4244-4250.
24. Rezaei N., Aghamohammadi A., Siadat S.D., Nejati M., Ahmadi H., Moin M., et al. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 2007, 25:5308-5314.
25. Rezaei N., Aghamohammadi A., Siadat S.D., Moin M., Pourpak Z., Nejati M., et al. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol 2008, 15:607-611.
26. Tønjum T., Koomey M. The pilus colonization factor of pathogenic neisserial species: organelle biogenesis and structure function relationships a review. Gene 1997, 192:155-163.
27. Collins R.F., Ford R.C., Kitmitto A., Olsen R.O., Tønjum T., Derrick J.P. Three-dimensional structure of the Neisseria meningitidis secretin PilQ determined from negative-stain transmission electron microscopy. J Bacteriol 2003, 185:2611-2617.
28. Halliwell D., Frye S.A., Taylor S., Flockhart A., Finney M., Reddin K. Immunization with the meningococcal PilQ complex is protective in a mouse model of meningococcal disease and elicits bactericidal and opsonic antibodies. 14th international pathogenic Neisseria conference 2004, p. 161.
29. Beernink P.T., Granoff D.M. Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H binding protein vaccines. Infect Immun 2008, 6:2568-2575.